Details for Patent: 9,688,665
✉ Email this page to a colleague
Which drugs does patent 9,688,665 protect, and when does it expire?
Patent 9,688,665 protects TAZVERIK and is included in one NDA.
This patent has one hundred patent family members in thirty-one countries.
Summary for Patent: 9,688,665
| Title: | Methods of treating cancer |
| Abstract: | The present invention relates to methods of treating cancer by administering the EZH2 inhibitor compounds and pharmaceutical compositions to subjects in need thereof. The present invention also relates to the use of such compounds for research or other non-therapeutic purposes. |
| Inventor(s): | Knutson; Sarah K. (Cambridge, MA), Warholic; Natalie (Brighton, MA), Keilhack; Heike (Belmont, MA) |
| Assignee: | Epizyme, Inc. (Cambridge, MA) |
| Application Number: | 14/054,646 |
|
Patent Claim Types: see list of patent claims | Use; |
Drugs Protected by US Patent 9,688,665
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Epizyme Inc | TAZVERIK | tazemetostat hydrobromide | TABLET;ORAL | 211723-001 | Jan 23, 2020 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | METHOD OF TREATING EPITHELIOID SARCOMA | ⤷ Try a Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 9,688,665
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Argentina | 093244 | ⤷ Try a Trial | |||
| Australia | 2013331368 | ⤷ Try a Trial | |||
| Australia | 2013331380 | ⤷ Try a Trial | |||
| Australia | 2013331381 | ⤷ Try a Trial | |||
| Australia | 2018233004 | ⤷ Try a Trial | |||
| Australia | 2020205261 | ⤷ Try a Trial | |||
| Australia | 2023282217 | ⤷ Try a Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
